search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Cancer@Work; a web-based intervention to improve the return-to-work of cancer survivors


- candidate number22357
- NTR NumberNTR5190
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR18-jun-2015
- Secondary IDsNL51798.018.14 METC AMC
- Public TitleCancer@Work; a web-based intervention to improve the return-to-work of cancer survivors
- Scientific TitleCancer@Work; a nurse-led web-based intervention to enhance the return-to-work of cancer survivors - a multicenter randomised controlled trial
- ACRONYMCancer@Work
- hypothesisThe patients who receive the stepped-care web-based intervention will have better work outcomes at 12 months of follow-up compared to patients who receive care as usual.
- Healt Condition(s) or Problem(s) studiedCancer patients
- Inclusion criteriaPrimary diagnosis of cancer
Treated with curative intent at the hospital of recruitment
Between 18-62 years old
In paid employment or self-employed at cancer diagnosis
- Exclusion criteriaHave a severe co-morbidity
Have no Internet access
Are not able to speak, read, and write Dutch sufficiently well
Receiving primary treatment in another hospital than hospital of recruitment
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-jul-2015
- planned closingdate1-sep-2019
- Target number of participants190
- InterventionsThe intervention consists of access to the web-based intervention, Cancer@Work, which will be blended with care by their specialised nurse or social worker. Cancer@Work, is an interactive, personal website, aimed at enhancing the return to work of cancer survivors by means of tailor-made information, assignments and movies. Patients will be supported in their use of Cancer@Work by their specialised nurse or social worker of their treating hospital.

The control group receives care as usual.
- Primary outcomeSustainable return to work measured as return to work (yes/no) which is sustained for at least four consecutive weeks. Return to work is regardless of partial return to work (working a part of contract hours) or full return to work (working all contract hours).
- Secondary outcomeFull return to work (working all contract hours) for at least four consecutive weeks.
Time in days to return to work (yes/no) for at least four consecutive weeks. Return to work is regardless of partial return to work (working a part of contract hours) or full return to work (working all contract hours).
Time in days to full return to work (working all contract hours) for at least four consecutive weeks.
Work ability
Work limitations
Quality of life
Quality of work life
Return to work without extensive need for recovery
Cost-effectiveness of the web-based intervention Cancer@Work
Feasibility of the web-based intervention Cancer@Work
Intermediate effect of the intervention on self-management and work-related self-efficacy.
- TimepointsBaseline 3, 6, 9 and 12 months after randomization
- Trial web site
- statusplanned
- CONTACT FOR PUBLIC QUERIESDrs. S.J. Tamminga
- CONTACT for SCIENTIFIC QUERIESDrs. S.J. Tamminga
- Sponsor/Initiator Academic Medical Center (AMC), Coronel Institute of Occupational Health
- Funding
(Source(s) of Monetary or Material Support)
Alpe díHuZes Foundation, Koningin Wilhelmina Fonds (KWF)
- Publications
- Brief summary
- Main changes (audit trail)15-jan-2016: EB
Amendement:
- End date: 01-sept-2019
- Participants: 190
- RECORD18-jun-2015 - 15-jan-2016


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl